Abstract
The article entitled, “MicroRNA-125b can Target p38MAPK to Resolve Intermittent Hypoxia-Induced Dementia in Murine Models” submitted in Current Neurovascular Research (CNR) by Dr. Xu Chen has been withdrawn from the journal in accordance with BSP Editorial Policies.
Current Neurovascular Research
Title:WITHDRAWN: MicroRNA-125b can Target p38MAPK to Resolve Intermittent Hypoxia- Induced Dementia in Murine Models
Volume: 16
Author(s): Haiyan Ren, Weibin Qiu, Chen Peng, Ying Ding, Benju Zhu, Qiang Li and Xu Chen*
Affiliation:
- Department of Neurology, Shanghai Eighth People’s Hospital, Shanghai,China
Abstract: The article entitled, “MicroRNA-125b can Target p38MAPK to Resolve Intermittent Hypoxia-Induced Dementia in Murine Models” submitted in Current Neurovascular Research (CNR) by Dr. Xu Chen has been withdrawn from the journal in accordance with BSP Editorial Policies.
Export Options
About this article
Cite this article as:
Ren Haiyan , Qiu Weibin, Peng Chen , Ding Ying, Zhu Benju , Li Qiang and Chen Xu *, WITHDRAWN: MicroRNA-125b can Target p38MAPK to Resolve Intermittent Hypoxia- Induced Dementia in Murine Models, Current Neurovascular Research 2019; 16() . https://dx.doi.org/10.2174/1567202616666190211155309
DOI https://dx.doi.org/10.2174/1567202616666190211155309 |
Print ISSN 1567-2026 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5739 |

- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The Hydroxamic Acids as Potential Anticancer and Neuroprotective Agents
Current Medicinal Chemistry Specific Targeting of Engineered Nanoparticles to Activated Macrophages
Current Nanoscience The Failure of Immunomodulation Therapy in Heart Failure: Does the Statins “Paradigm” Prove the Rule?
Current Vascular Pharmacology The Application of Proteomics in Neurology
Current Proteomics Inflammatory Process in Alzheimer’s and Parkinson's Diseases: Central Role of Cytokines
Current Pharmaceutical Design Reconstructing the Hsp90/Tau Machine
Current Enzyme Inhibition Implication of Green Tea as a Possible Therapeutic Approach for Parkinson Disease
CNS & Neurological Disorders - Drug Targets Neurogenesis in the Adult Brain: Implications for Alzheimers Disease
CNS & Neurological Disorders - Drug Targets The Effects of Psychological Stress on Depression
Current Neuropharmacology Methylphenidate on Cognitive Improvement in Patients with Traumatic Brain Injury: A Meta-Analysis
Current Neuropharmacology Virgin Olive Oil and Hypertension
Current Vascular Pharmacology Tau Pathology and Future Therapeutics
Current Alzheimer Research Change in INSR, APBA2 and IDE Gene Expressions in Brains of Alzheimer's Disease Patients
Current Alzheimer Research Histone Deacetylase Inhibitors and Neurodegenerative Disorders: Holding the Promise
Current Pharmaceutical Design Complement C4A and C4B Gene Copy Number Study in Alzheimer's Disease Patients
Current Alzheimer Research Ceruloplasmin, the Unique Multi-Copper Oxidase of Vertebrates
Protein & Peptide Letters Centralized and Local Color Doppler Ultrasound Reading Agreement for Diagnosis of the Chronic Cerebrospinal Venous Insufficiency in Patients with Multiple Sclerosis
Current Neurovascular Research Dementia After Age 75: Survival in Different Severity Stages and Years of Life Lost
Current Alzheimer Research Brain: The Potential Diagnostic and Therapeutic Target for Glaucoma
CNS & Neurological Disorders - Drug Targets Body Mass Index in Midlife and Risk of Alzheimer Disease and Vascular Dementia
Current Alzheimer Research